carbachol has been researched along with Lacrimal Duct Obstruction in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Lacrimal Duct Obstruction: Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)
Excerpt | Relevance | Reference |
---|---|---|
" For timolol, nasolacrimal occlusion collapsed the dose-response curve and extended the duration of action." | 2.67 | Therapeutic index of pilocarpine, carbachol, and timolol with nasolacrimal occlusion. ( Fuqua, M; Nardin, GF; Sharir, M; Zimmerman, TJ, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Su, JZ | 1 |
Liu, XJ | 1 |
Wang, Y | 1 |
Cai, ZG | 1 |
Zhang, L | 1 |
Lv, L | 1 |
Wang, Z | 1 |
Hong, X | 1 |
Yu, GY | 1 |
Zimmerman, TJ | 1 |
Sharir, M | 1 |
Nardin, GF | 1 |
Fuqua, M | 1 |
1 trial available for carbachol and Lacrimal Duct Obstruction
Article | Year |
---|---|
Therapeutic index of pilocarpine, carbachol, and timolol with nasolacrimal occlusion.
Topics: Absorption; Carbachol; Chronic Disease; Cornea; Dose-Response Relationship, Drug; Double-Blind Metho | 1992 |
1 other study available for carbachol and Lacrimal Duct Obstruction
Article | Year |
---|---|
Effects of Capsaicin and Carbachol on Secretion From Transplanted Submandibular Glands and Prevention of Duct Obstruction.
Topics: Adolescent; Adult; Aged; Capsaicin; Carbachol; Child; Cholinergic Agonists; Drug Combinations; Femal | 2016 |